These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [A randomized comparison of carvedilol and metoprolol in patients with chronic heart failure. The Carvedilol Or Metoprolol European Trial (COMET) ]. Torp-Pedersen CT; Ugeskr Laeger; 2004 Aug; 166(32):2671-4. PubMed ID: 15347171 [No Abstract] [Full Text] [Related]
45. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial). Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA; Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806 [TBL] [Abstract][Full Text] [Related]
47. Role of carvedilol in atrial fibrillation: insights from clinical trials. Gheorghiade M; Lukas MA Am J Cardiol; 2004 May; 93(9A):53B-7B. PubMed ID: 15144939 [TBL] [Abstract][Full Text] [Related]
48. Special considerations for carvedilol use in heart failure. Yancy CW Am J Cardiol; 2004 May; 93(9A):64B-8B. PubMed ID: 15144941 [TBL] [Abstract][Full Text] [Related]
49. [Beta blockers: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects]. Kawano S Nihon Rinsho; 2007 May; 65 Suppl 5():91-7. PubMed ID: 17571371 [No Abstract] [Full Text] [Related]
57. Bucindolol: new hopes from reviewing past data. Fiuzat M; O'Connor CM Drugs Today (Barc); 2011 May; 47(5):347-51. PubMed ID: 22013565 [TBL] [Abstract][Full Text] [Related]